Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Isatuximab
Trade Name Sarclisa
Synonyms SAR650984|isatuximab-irfc
Drug Descriptions

Sarclisa (isatuximab-irfc) is a humanized monoclonal antibody against CD38 that induces anti-tumor immune reaction against CD38-positive tumor cells (PMID: 24987056). Sarclisa (isatuximab-irfc) in combination with Pomalyst (pomalidomide) and dexamethasone is FDA approved for use in patients with multiple myeloma who have received two or more prior therapies, and in combination with Kyprolis (carfilzomib) and dexamethasone for patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy (FDA.gov).

DrugClasses CD38 Antibody 16
CAS Registry Number 1461640-62-9
NCIT ID C90578


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Isatuximab Atezolizumab Isatuximab 0 3
belantamab mafodotin-blmf + Isatuximab Isatuximab belantamab mafodotin-blmf 0 1
Bendamustine + Isatuximab + Prednisone Bendamustine Isatuximab Prednisone 0 1
Bortezomib + Cyclophosphamide + Dexamethasone + Isatuximab Bortezomib Cyclophosphamide Dexamethasone Isatuximab 0 1
Bortezomib + Dexamethasone + Isatuximab Bortezomib Dexamethasone Isatuximab 0 1
Bortezomib + Dexamethasone + Isatuximab + Lenalidomide Bortezomib Dexamethasone Isatuximab Lenalidomide 0 3
Carfilzomib + Dexamethasone + Isatuximab Carfilzomib Dexamethasone Isatuximab 0 1
Carfilzomib + Dexamethasone + Isatuximab + Lenalidomide Carfilzomib Dexamethasone Isatuximab Lenalidomide 0 4
Carfilzomib + Dexamethasone + Isatuximab + Pomalidomide Carfilzomib Dexamethasone Isatuximab Pomalidomide 0 1
Carfilzomib + Isatuximab Carfilzomib Isatuximab 0 1
Carfilzomib + Isatuximab + Lenalidomide Carfilzomib Isatuximab Lenalidomide 0 1
Carfilzomib + Isatuximab + Pomalidomide Carfilzomib Isatuximab Pomalidomide 0 2
Cemiplimab + Isatuximab Cemiplimab Isatuximab 0 2
Dexamethasone + Elotuzumab + Isatuximab + Pomalidomide Dexamethasone Elotuzumab Isatuximab Pomalidomide 0 1
Dexamethasone + Isatuximab Dexamethasone Isatuximab 0 1
Dexamethasone + Isatuximab + Lenalidomide Dexamethasone Isatuximab Lenalidomide 0 5
Dexamethasone + Isatuximab + Pomalidomide Dexamethasone Isatuximab Pomalidomide 0 5
Dexamethasone + Isatuximab + SAR439459 Dexamethasone Isatuximab SAR439459 0 1
Diphenhydramine + Isatuximab + Methylprednisolone + Ranitidine Diphenhydramine Isatuximab Methylprednisolone Ranitidine 0 1
Isatuximab Isatuximab 0 9

Additional content available in CKB BOOST